These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37505758)

  • 1. Detection of Chitinase 3-Like 1 in Symptomatic Primary Care Patient Faecal Samples is Not a Reliable Biomarker of Colonic Lesions.
    Keenan JI; Aitchison A; Frizelle FA; Hock BD
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2289-2293. PubMed ID: 37505758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
    Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
    Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
    Pin Vieito N; Zarraquiños S; Cubiella J
    World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal biomarkers do not always identify pre-cancerous lesions in patients who present in primary care with bowel symptoms.
    Keenan J; Aitchison A; Leaman J; Pearson J; Frizelle F
    N Z Med J; 2019 Aug; 132(1501):48-56. PubMed ID: 31465327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
    Widlak MM; Neal M; Daulton E; Thomas CL; Tomkins C; Singh B; Harmston C; Wicaksono A; Evans C; Smith S; Savage RS; Covington JA; Arasaradnam RP
    Colorectal Dis; 2018 Dec; 20(12):O335-O342. PubMed ID: 30248228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
    Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients.
    Widlak MM; Thomas CL; Thomas MG; Tomkins C; Smith S; O'Connell N; Wurie S; Burns L; Harmston C; Evans C; Nwokolo CU; Singh B; Arasaradnam RP
    Aliment Pharmacol Ther; 2017 Jan; 45(2):354-363. PubMed ID: 27910113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.
    Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J
    United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the QuikRead go
    Maclean W; Zahoor Z; O'Driscoll S; Piggott C; Whyte MB; Rockall T; Jourdan I; Benton SC
    Clin Chem Lab Med; 2022 Jan; 60(1):101-108. PubMed ID: 34679264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.
    Aomatsu T; Imaeda H; Matsumoto K; Kimura E; Yoden A; Tamai H; Fujiyama Y; Mizoguchi E; Andoh A
    Aliment Pharmacol Ther; 2011 Oct; 34(8):941-8. PubMed ID: 21848856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population.
    Stonestreet J; Chandrapalan S; Woolley D; Uthman U; Arasaradnam RP
    Acta Gastroenterol Belg; 2019; 82(2):291-299. PubMed ID: 31314191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
    Högberg C; Karling P; Rutegård J; Lilja M
    Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating faecal haemoglobin measurement using the faecal immunochemical test (FIT) in the referral, triage and prioritisation pathway for patients with colorectal symptoms.
    Falvey J; Frampton CMA; Gearry RB; Hudson B; Whiteley L
    N Z Med J; 2023 Jul; 136(1578):55-76. PubMed ID: 37414077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems.
    Benton SC; Piggott C; Zahoor Z; O'Driscoll S; Fraser CG; D'Souza N; Chen M; Georgiou Delisle T; Abulafi M
    Clin Chem Lab Med; 2022 Jul; 60(8):1278-1286. PubMed ID: 35637625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
    Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ
    Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of faecal haemoglobin based triage of bowel symptoms presenting to primary care on colorectal cancer diagnosis.
    Delson D; Ward M; Haddock R; Nobes J; Digby J; Strachan JA; Mowat C
    Colorectal Dis; 2023 Apr; 25(4):787-793. PubMed ID: 36495081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
    Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
    Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal immunochemical testing (FIT) in primary care: a follow-up service evaluation.
    Ayling RM; Machesney M
    J Clin Pathol; 2024 Jun; 77(7):495-499. PubMed ID: 37072172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of repeat faecal immunochemical testing in symptomatic patients attending primary care.
    Johnstone MS; MacLeod C; Digby J; Al-Azzawi Y; Pang G; Watson AJM; Strachan J; Mowat C; McSorley ST
    Colorectal Dis; 2022 Dec; 24(12):1498-1504. PubMed ID: 35776684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.